These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 38839295)

  • 1. Epilepsy in Patients with Gliomas.
    Ehara T; Ohka F; Motomura K; Saito R
    Neurol Med Chir (Tokyo); 2024 Jul; 64(7):253-260. PubMed ID: 38839295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multi-omics technologies and molecular biomarkers in brain tumor-related epilepsy.
    Du Y; Li R; Fu D; Zhang B; Cui A; Shao Y; Lai Z; Chen R; Chen B; Wang Z; Zhang W; Chu L
    CNS Neurosci Ther; 2024 Apr; 30(4):e14717. PubMed ID: 38641945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation of Clinicopathological Factors with Brain Tumor-Related Epilepsy in Glioma.
    Wang Z; Yang W; Wang Y; Aili Y; Wang Z; Wang Q; Jiang S; Zhang G; Zhang J; Li B
    Dis Markers; 2022; 2022():4918294. PubMed ID: 36246555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumoral epileptogenicity: how does it happen?
    Pallud J; Capelle L; Huberfeld G
    Epilepsia; 2013 Dec; 54 Suppl 9():30-4. PubMed ID: 24328869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brain tumor related-epilepsy.
    Goldstein ED; Feyissa AM
    Neurol Neurochir Pol; 2018 Aug; 52(4):436-447. PubMed ID: 30122210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Onco-Epilepsy: More Than Tumor and Seizures.
    Tatum WO; Quinones-Hinojosa A
    Mayo Clin Proc; 2018 Sep; 93(9):1181-1184. PubMed ID: 30104043
    [No Abstract]   [Full Text] [Related]  

  • 7. Seizure control as a new metric in assessing efficacy of tumor treatment in low-grade glioma trials-impact of psychogenic non-epileptic seizures.
    Morrow AM; Morgan RM; Villano JL
    Neuro Oncol; 2017 Jul; 19(7):1010-1011. PubMed ID: 28586447
    [No Abstract]   [Full Text] [Related]  

  • 8. Quality of life, mood and seizure control in patients with brain tumor related epilepsy treated with lacosamide as add-on therapy: A prospective explorative study with a historical control group.
    Maschio M; Zarabla A; Maialetti A; Fabi A; Vidiri A; Villani V; Giannarelli D
    Epilepsy Behav; 2017 Aug; 73():83-89. PubMed ID: 28623754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor-associated epilepsy and glioma: are there common genetic pathways?
    Berntsson SG; Malmer B; Bondy ML; Qu M; Smits A
    Acta Oncol; 2009; 48(7):955-63. PubMed ID: 19639468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Seizure control as a new metric in assessing efficacy of tumor treatment in low-grade glioma trials.
    Avila EK; Chamberlain M; Schiff D; Reijneveld JC; Armstrong TS; Ruda R; Wen PY; Weller M; Koekkoek JA; Mittal S; Arakawa Y; Choucair A; Gonzalez-Martinez J; MacDonald DR; Nishikawa R; Shah A; Vecht CJ; Warren P; van den Bent MJ; DeAngelis LM
    Neuro Oncol; 2017 Jan; 19(1):12-21. PubMed ID: 27651472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epilepsy in patients with gliomas: incidence and control of seizures.
    Iuchi T; Hasegawa Y; Kawasaki K; Sakaida T
    J Clin Neurosci; 2015 Jan; 22(1):87-91. PubMed ID: 25192590
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Glioma-associated epilepsy].
    Lian K; Engelsen B; Storstein A
    Tidsskr Nor Laegeforen; 2012 Aug; 132(15):1752-6. PubMed ID: 22929942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High expression of cystine-glutamate antiporter xCT (SLC7A11) is an independent biomarker for epileptic seizures at diagnosis in glioma.
    Sørensen MF; Heimisdóttir SB; Sørensen MD; Mellegaard CS; Wohlleben H; Kristensen BW; Beier CP
    J Neurooncol; 2018 May; 138(1):49-53. PubMed ID: 29404978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epilepsy in the end-of-life phase in patients with high-grade gliomas.
    Pace A; Villani V; Di Lorenzo C; Guariglia L; Maschio M; Pompili A; Carapella CM
    J Neurooncol; 2013 Jan; 111(1):83-6. PubMed ID: 23086435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemotherapy and immunotherapy of brain tumors: what the epileptologist must know.
    Rogers LR
    Epilepsia; 2013 Dec; 54 Suppl 9():105-8. PubMed ID: 24328882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Indolent glioma: a cause of epilepsy.
    Lee TK; Nakasu Y; Jeffree MA; Molyneux AJ; Adams CB
    Arch Dis Child; 1989 Dec; 64(12):1666-71. PubMed ID: 2624473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Seizures and gliomas--towards a single therapeutic approach.
    Huberfeld G; Vecht CJ
    Nat Rev Neurol; 2016 Apr; 12(4):204-16. PubMed ID: 26965673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lacosamide on background eeg activity in brain tumor-related epilepsy patients: A case series study.
    Maschio M; Zarabla A; Maialetti A; Sperati F; Dinapoli L; Dispenza S; Petreri G; Cantelmi T
    Brain Behav; 2018 Nov; 8(11):e01067. PubMed ID: 30334378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical practice guidelines for the diagnosis and treatment of adult diffuse glioma-related epilepsy.
    Liang S; Fan X; Zhao M; Shan X; Li W; Ding P; You G; Hong Z; Yang X; Luan G; Ma W; Yang H; You Y; Yang T; Li L; Liao W; Wang L; Wu X; Yu X; Zhang J; Mao Q; Wang Y; Li W; Wang X; Jiang C; Liu X; Qi S; Liu X; Qu Y; Xu J; Wang W; Song Z; Wu J; Liu Z; Chen L; Lin Y; Zhou J; Liu X; Zhang W; Li S; Jiang T
    Cancer Med; 2019 Aug; 8(10):4527-4535. PubMed ID: 31240876
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical characteristics of epileptic seizures in insular gliomas].
    Buklina SB; Bykanov AE; Pitskhelauri DI
    Zh Nevrol Psikhiatr Im S S Korsakova; 2016; 116(12):13-19. PubMed ID: 28139619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.